Biodesix Receives $11,000,000 Series E Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2970 Wilderness Place Boulder, CO 80301 USA
  • Company Description
    Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    The investment will be used for ongoing new product development and expansion of commercial efforts to support Biodesix’ commercialized products, VeriStrat and GeneStrat, as well as new product launches in 2015 – 2016.
  • M&A Terms
  • Venture Investor

Trending on Xconomy